Avalo Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Avalo Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Avalo Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 79.9 %, a 5.66% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 79.9 +4.28 +5.66% Sep 30, 2024
Q2 2024 70.7 -2.17 -2.98% Jun 30, 2024
Q1 2024 56.2 -32.7 -36.8% Mar 31, 2024
Q4 2023 84.9 -43.6 -33.9% Dec 31, 2023
Q3 2023 75.7 -121 -61.4% Sep 30, 2023
Q2 2023 72.9 -201 -73.4% Jun 30, 2023
Q1 2023 88.9 -204 -69.6% Mar 31, 2023
Q4 2022 129 -139 -51.9% Dec 31, 2022
Q3 2022 196 -42.5 -17.8% Sep 30, 2022
Q2 2022 274 +72.5 +36.1% Jun 30, 2022
Q1 2022 293 +68.3 +30.4% Mar 31, 2022
Q4 2021 267 +35.8 +15.5% Dec 31, 2021
Q3 2021 239 +9.46 +4.13% Sep 30, 2021
Q2 2021 201 +22.4 +12.5% Jun 30, 2021
Q1 2021 225 +115 +105% Mar 31, 2021
Q4 2020 231 +138 +149% Dec 31, 2020
Q3 2020 229 +146 +176% Sep 30, 2020
Q2 2020 179 +96 +116% Jun 30, 2020
Q1 2020 110 +29.4 +36.6% Mar 31, 2020
Q4 2019 93 +15.7 +20.3% Dec 31, 2019
Q3 2019 83.2 +5.3 +6.81% Sep 30, 2019
Q2 2019 82.7 -46 -35.7% Jun 30, 2019
Q1 2019 80.4 -99.2 -55.3% Mar 31, 2019
Q4 2018 77.3 -160 -67.4% Dec 31, 2018
Q3 2018 77.9 -241 -75.6% Sep 30, 2018
Q2 2018 129 -22.9 -15.1% Jun 30, 2018
Q1 2018 180 +29.3 +19.5% Mar 31, 2018
Q4 2017 237 +53.2 +28.9% Dec 31, 2017
Q3 2017 319 +84.6 +36.1% Sep 30, 2017
Q2 2017 152 -66.4 -30.5% Jun 30, 2017
Q1 2017 150 Mar 31, 2017
Q4 2016 184 Dec 31, 2016
Q3 2016 234 Sep 30, 2016
Q2 2016 218 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.